The French contraceptive market is estimated at nearly €530 million in 2022. The global market is estimated at around $22-23 billion, and is expected to reach $30 billion by 2027. This expansion is attributed to population growth, increased government initiatives to raise awareness of unwanted pregnancies and sexually transmitted infections (STIs), and changing lifestyles that delay childbearing. France stands out in Europe for its relatively easy access to contraception, with a score of 90.1% for contraceptive accessibility in 2020. The main players on the global market are Allergan Plc, Bayer AG and Merck. The French contraceptive market A variety of contraceptive methods are used, with hormonal pills, intrauterine devices (IUDs) and condoms being the most widespread. In France, around a third of women opt for the contraceptive pill, a quarter for the IUD and around 16% for the condom.preferences change with age: women aged 15 to 34 prefer the pill, while those aged 35 to 49 prefer t
